Skip to content
Research Article Open access CC BY 4.0

Opportunities to Topically Reduce Intraocular Pressure in Glaucoma

Ognjenka Rahić, Amina Tucak, Merima Sirbubalo, Lamija Hindija, Jasmina Hadžiabdić, Edina Vranić

Ophthalmology Research: An International Journal · pp. 17–33 · Published 13 Mar 2021

10.9734/or/2021/v14i230189

Abstract

Since glaucoma is a serious health problem, numerous therapeutics are being developed to reduce Intraocular Pressure (IOP) as the only modifiable factor of all glaucoma symptoms. IOP-lowering agents are divided into six groups, each of which has a specific mechanism of action and side effects, which are the focus of this article and are explained in detail. All the mentioned agents are formulated as eye drops. However, as conventional topical eye drops have significant disadvantages, of which poor bioavailability and patient noncompliance are the main, novel approaches to designing their drug delivery systems were used and briefly presented in this review.

Glaucoma glaucoma treatment intraocular pressure novel drug delivery systems

Cited by 3

Electrosprayed core-shell nanoparticles for sustained release fixed combination monotherapy in glaucoma treatment

Gitika Kumari, T. S. Sampath Kumar, M. Zare · Journal of Drug Delivery Science and Technology · 2023

Article metrics

Real usage data collected on this platform.

40

Page views

0

PDF downloads

4

Outbound clicks

3

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.